Fimasartan Potassium Trihydrate, CAS 1020110-23-9 Sole GMP Manufacturer
Fimasartan Potassium Trihydrate, CAS 1020110-23-9 stable novel crystalline or amorphous form both we have, Fimasartan Potassium Trihydrate, CAS 1020110-23-9no any IP problem. Fimasartan Potassium Trihydrate, CAS 1020110-23-9 DMF filling, free sample of Fimasartan Potassium Trihydrate, CAS 1020110-23-9.
EOS Med Chem have already carried out Fimasartan Potassium Trihydrate, CAS 1020110-23-9 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Fimasartan Potassium Trihydrate, CAS 1020110-23-9 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Fimasartan Potassium Trihydrate, CAS 1020110-23-9 Intermeidates list, most from GMP plant:
Fimasartan Potassium Trihydrate, CAS 1020110-23-9 HNMR, MASS, COA, MSDS we have.
Fimasartan Potassium Trihydrate, CAS 1020110-23-9, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
Fimasartan Potassium Trihydrate, CAS 1020110-23-9 stable novel crystalline or amorphous form both we have, Fimasartan Potassium Trihydrate, CAS 1020110-23-9no any IP problem. Fimasartan Potassium Trihydrate, CAS 1020110-23-9 DMF filling, free sample of Fimasartan Potassium Trihydrate, CAS 1020110-23-9.
EOS Med Chem have already carried out Fimasartan Potassium Trihydrate, CAS 1020110-23-9 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Fimasartan Potassium Trihydrate, CAS 1020110-23-9 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Fimasartan Potassium Trihydrate, CAS 1020110-23-9 Intermeidates list, most from GMP plant:
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 1115-30-6, stock 6.1kg, assay 98.7%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 109-51-3, stock 1.5kg, assay 98.2%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 503155-65-5, stock 6.5kg, assay 98.8%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 503155-66-6, stock 3.6kg, assay 98.5%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 1361024-33-0, stock 1.8kg, assay 98.8%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 503155-67-7, stock 5.8kg, assay 98.5%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 1361024-52-3, stock 5.6kg, assay 98%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 2675-89-0, stock 7.4kg, assay 98.3%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 1315478-14-8, stock 7.6kg, assay 98.6%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 18257-46-0, stock 4.2kg, assay 98.7%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 120568-11-8, stock 3.1kg, assay 98%, White powder. |
| Fimasartan Potassium Trihydrate, CAS 1020110-23-9;247257-48-3 (free) Intermediate 124750-53-4, stock 1.7kg, assay 98%, White powder. |
Fimasartan Potassium Trihydrate, CAS 1020110-23-9 HNMR, MASS, COA, MSDS we have.
Fimasartan Potassium Trihydrate, CAS 1020110-23-9, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
























































